Alnylam Pharmaceuticals

$134.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$3.20 (-2.31%) Today

-$1.03 (-0.76%) As of 9:23 PM UTC after-hours

Why Robinhood?

You can buy or sell ALNY and other stocks, options, and ETFs commission-free!

About ALNY

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. The firm's products include ONPATTRO, GIVLAARI, and OXLUMO.

CEO

John M. Maraganore

Employees

1,453

Headquarters

Cambridge, Massachusetts

Founded

2002

Market Cap

15.79B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

434.95K

High Today

$137.87

Low Today

$134.09

Open Price

$137.08

Volume

521.72K

52 Week High

$178.41

52 Week Low

$114.30

Analyst Ratings

57%

of 23 ratings

Buy

57%

Hold

43%

Sell

ALNY Earnings

-$2.23

-$1.49

-$0.74

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 5, Pre-Market